Leadership
<span data-metadata=""><span data-buffer="">Leadership
Robert Mitchell | Chief Executive Officer
Founder RDM Enterprises. CEO N8 Medical, Cora Therapeutics Nellix Inc, Millimed Holdings, President Endologix, COO Angio Dynamics, SVP Cook Medical, EVP Align Technologies.
Carl Genberg, B.Sc. J.D. | Chief Development and Science Officer
Olga Yanvoskaya | International Sales & Marketing
Glenn Brunner | Quality Assurance
Chief Executive Officer | In Transition
In Transition
Carl Genberg, B.Sc. J.D. | Chief Development and Science Officer
Olga Yanvoskaya | International Sales & Marketing
Glenn Brunner | Quality Assurance
Board of Directors
Jay Golding | Chairman
Robert Mitchell | Director/Chief Executive Officer
Jay Golding | Chairman
Raymond K. Houck | Director
Current CEO of Aclipse Therapeutics, Former CEO & Co-Founder of Thar Pharmaceuticals, Automated Cell, and Suprex Corporation
Carl Genberg, JD | Director/Chief Development and Science Officer
Entrepreneur, Scientist, Regulatory Specialist, Inventor. Co-founder of Goldman Sachs funded medical device company, achieved $1 Billion market cap at its peak.
Peter Allen | Director
Industry veteran led Becton Dickinson IV catheter business, EVP for Vizient, the worlds largest GPO.
Henry Haimsohn | Director
Shawn Langer | Director
Chief Advisors
Chief Advisors
Paul Savage, PhD | Science and Chemistry
Ronald Bracken | Coatings and Operations
Industry veteran, Former VP of R&D at CR Bard leading antimicrobial device coatings.
Michael Niederman | Critical Care Medicine
David Perlin, PhD | Medical Research
Highly accomplished medical researcher. Chief Scientific Officer and SVP for Hackensack Meridian Health Center for discover and innovation
Jorge Hildago, M.D. | Critical Care Medicine
Lisa Dwyer | Regulatory Strategy
Don Boyer | Canadian Regulatory
John Doucet | Regulatory Strategy
Matthew Reed, PhD | Toxicology with Expertise in Cystic Fibrosis
Michelle Higgin, PhD | Program Leadership
Dale Christensen, PhD | Clinical Development
Tom Richardson, PhD | Science and Chemistry
Jeffrey Wang, M.D. | Toxicology with Expertise in Cystic Fibrosis
Michael John | Regulatory Strategy
Chief of the Interventional Cardiology Devices Branch in the Division of Cardiovascular Devices at the US Food and Drug Administration.
Georg Wieselthaler, M.D. | SBIR Consultant – Cardiology KOL
UCSF’s director and surgical chief of Cardiac Transplantation and Mechanical Circulatory Support.
Prabir Roy-Chaudhury, M.D. | SBIR Consultant – Kidney KOL
Contact us
Lets Get in Touch!
- info@n8medical.com
- N8 Medical LLC - 545 Metro Place, Dublin, OH, 43107
mynewform
Basic contact form
N8 Medical, Inc. (N8 Medical) is a clinical-stage medical device company focused on commercializing medical devices that incorporate a novel class of active compounds called ceragenins.The subsidiaries for N8 Medical Inc are N8 Medical, LLC for Medical Device Development and Kinnear Pharmaceuticals, LLC for drug development.